-

Acadia Healthcare to Participate in March Investor Conferences

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in March.

On Tuesday, March 7, 2023, the Company will participate in the Raymond James 44th Annual Institutional Investors Conference, which is being held March 5 - 8, 2023, in Orlando, Florida. The Company’s presentation will be at 6:30 a.m. Central Time/7:30 a.m. Eastern Time.

On Wednesday, March 8, 2023, the Company will participate in the Cowen 43rd Annual Health Care Conference, to be held March 6 - 8, 2023, in Boston, Massachusetts. The Company’s presentation will be at 9:30 a.m. Central Time/10:30 a.m. Eastern Time.

The live webcast of both presentations will be available on the Company’s website, www.acadiahealthcare.com, by clicking on the “Investors” link. A replay of the presentation will also be available on the Company’s website for 30 days.

About Acadia

Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2022, Acadia operated a network of 250 behavioral healthcare facilities with approximately 11,000 beds in 39 states and Puerto Rico. With approximately 23,000 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Contacts

Gretchen Hommrich
Vice President, Investor Relations
(615) 861-6000

Acadia Healthcare Company, Inc.

NASDAQ:ACHC

Release Versions

Contacts

Gretchen Hommrich
Vice President, Investor Relations
(615) 861-6000

More News From Acadia Healthcare Company, Inc.

Acadia Healthcare Announces Fourth Quarter and 2025 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company’s previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an...

Acadia Healthcare to Participate in March Investor Conferences

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of...
Back to Newsroom